Taysha Gene Therapies, Inc. (TSHA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.51
Day's range
$4.77

Taysha Gene Therapies Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 23.56 M $105.29 M   0.00% 7.37%
GOLDMAN SACHS GROUP INC 05/15/2026 22.37 M $99.99 M   63.37% 7.00%
AVORO CAPITAL ADVISORS LLC 05/15/2026 21.70 M $97.00 M   0.00% 6.79%
BLACKROCK, INC. 05/13/2026 18.37 M $82.09 M   -1.49% 5.74%
VESTAL POINT CAPITAL, LP 05/15/2026 18.00 M $80.46 M   30.91% 5.63%
MORGAN STANLEY 05/15/2026 17.97 M $80.31 M   -0.63% 5.62%
FMR LLC 05/15/2026 14.32 M $64.02 M   5.86% 4.48%
RTW INVESTMENTS, LP 05/15/2026 13.68 M $61.15 M   -16.58% 4.28%
STATE STREET CORP 05/15/2026 11.21 M $50.10 M   3.88% 3.51%
05/15/2026 10.23 M $45.73 M   100.00% 3.20%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 8.86 M $39.60 M   0.00% 2.77%
SIREN, L.L.C. 05/14/2026 8.83 M $39.47 M   -12.83% 2.76%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 5.65 M $25.27 M   -28.71% 1.77%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 5.53 M $24.73 M   2.69% 1.73%
D. E. SHAW & CO., INC. 05/15/2026 4.43 M $19.79 M   10.31% 1.38%
BAKER BROS. ADVISORS LP 05/15/2026 4.00 M $17.90 M   0.00% 1.25%
MILLENNIUM MANAGEMENT LLC 05/15/2026 3.28 M $14.67 M   3.24% 1.03%
CASDIN CAPITAL, LLC 05/15/2026 3.25 M $14.53 M   116.67% 1.02%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 2.98 M $13.32 M   19.38% 0.93%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 05/14/2026 2.88 M $12.89 M   -22.53% 0.90%
BARCLAYS PLC 05/15/2026 2.81 M $11.44 M   -49.23% 0.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 2.72 M $12.17 M   0.00% 0.85%
SG AMERICAS SECURITIES, LLC 04/16/2026 2.18 M $9.73 M   178.54% 0.68%
05/08/2026 2.02 M $9.04 M   100.00% 0.63%
RICE HALL JAMES & ASSOCIATES, LLC 05/15/2026 1.94 M $8.69 M   53.05% 0.61%
NORTHERN TRUST CORP 05/14/2026 1.81 M $8.11 M   46.55% 0.57%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.81 M $8.08 M   -4.96% 0.57%
B GROUP, INC. 05/15/2026 1.80 M $8.05 M   0.00% 0.56%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.68 M $7.50 M   45.49% 0.52%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.53 M $6.84 M   100.00% 0.48%
PALO ALTO INVESTORS LP 05/15/2026 1.39 M $6.22 M   17.60% 0.44%
ABRDN PLC 04/29/2026 1.02 M $4.56 M   0.00% 0.32%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 1.00 M $4.47 M   -69.70% 0.31%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2026 883.24 K $3.95 M   25.47% 0.28%
QUANTUM PRIVATE WEALTH, LLC 04/27/2026 849.21 K $3.80 M   3.60% 0.27%
JPMORGAN CHASE & CO 05/13/2026 754.78 K $3.07 M   -2.53% 0.24%
TWO SIGMA INVESTMENTS, LP 05/15/2026 742.08 K $3.32 M   111.34% 0.23%
05/15/2026 737.55 K $22.22 M   -44.58% 0.23%
SANDS CAPITAL VENTURES, LLC 05/08/2026 724.87 K $3.24 M   0.00% 0.23%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 626.36 K $2.80 M   -11.93% 0.20%
06/04/2026 625.71 K $2.80 M   274.18% 0.20%
BANK OF NEW YORK MELLON CORP 05/05/2026 608.12 K $2.72 M   -2.60% 0.19%
NUVEEN, LLC 04/30/2026 549.15 K $2.45 M   0.71% 0.17%
UBS GROUP AG 05/05/2026 517.70 K $2.31 M   35.15% 0.16%
WOODLINE PARTNERS LP 05/15/2026 513.83 K $2.30 M   2.77% 0.16%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 511.98 K $2.29 M   134.66% 0.16%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 490.47 K $2.18 M   0.00% 0.15%
JEFFERIES FINANCIAL GROUP INC. 05/08/2026 479.00 K $2.14 M   1,816.00% 0.15%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 461.86 K $2.06 M   -88.06% 0.14%
ACUTA CAPITAL PARTNERS, LLC 05/15/2026 439.46 K $1.96 M   -3.38% 0.14%

Taysha Gene Therapies Inc institutional Ownership - FAQ's

During the previous two years, 229 institutional investors and hedge funds held shares of Taysha Gene Therapies Inc. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 23.56 M

GOLDMAN SACHS GROUP INC: 22.37 M

Avoro Capital Advisors LLC: 21.7 M

BlackRock, Inc.: 18.37 M

Vestal Point Capital, LP: 18 M

MORGAN STANLEY: 17.97 M

83.08% of Taysha Gene Therapies Inc stock is owned by institutional investors.

Institutional investors have bought a total of 285.57 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.